JLens 500 Jewish Advocacy U.S. ETF Rating $32.39 -0.43 (-1.31%) As of 02:36 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsNews and TrendsOwnershipRatingsShort Interest JLens 500 Jewish Advocacy U.S. ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.TOV Aggregate RatingModerate Buy 2.84Holdings in TOV have an aggregate rating of Moderate Buy based on 945 analyst ratings issued in the past year covering 25 companies (53.2% of the portfolio).TOV Aggregate Price Target$32.460.29% UpsideHigh Prediction$32.46Average Prediction$32.46Low Prediction$32.46Holdings in TOV have an aggregate price target of $32.46 and a range of $32.46 to $32.46 covering 25 companies (53.2% of the portfolio).TOV Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy18 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by JLens 500 Jewish Advocacy U.S. ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 TOV Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings8.39%NVDANVIDIA$220.44-3.5%Buy$321.89 46.0%554.8758 of 5 starsTrending News7.13%AAPLApple$343.22+0.6%Moderate Buy$340.39 -0.8%424.3119 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision5.81%MSFTMicrosoft$533.98-1.7%Moderate Buy$581.80 9.0%484.9035 of 5 starsTrending NewsAnalyst DowngradeAnalyst Revision5.13%GOOGLAlphabet$347.42-1.8%Buy$425.74 22.5%554.8495 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision3.62%AMZNAmazon.com$253.43-2.0%Moderate Buy$322.53 27.3%594.9008 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision2.49%AVGOBroadcom$344.87-3.5%Moderate Buy$527.20 52.9%414.9231 of 5 starsTrending NewsAnalyst Revision2.40%METAMeta Platforms$736.68-3.4%Moderate Buy$801.53 8.8%574.3783 of 5 starsTrending NewsUpcoming EarningsAnalyst ForecastAnalyst Revision1.75%MUMicron Technology$923.05-3.2%Moderate Buy$1,407.88 52.5%464.9987 of 5 starsTrending NewsAnalyst UpgradeAnalyst Revision1.57%TSLATesla$364.43-2.9%Hold$412.33 13.1%463.9025 of 5 starsTrending NewsUpcoming EarningsAnalyst ForecastAnalyst Revision1.51%AMDAdvanced Micro Devices$570.98-5.7%Moderate Buy$603.51 5.7%433.7162 of 5 starsTrending NewsGap Down1.46%LLYEli Lilly and Company$1,211.74+3.9%Moderate Buy$1,313.43 8.4%294.7402 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision1.38%BRK.BBerkshire Hathaway$526.03+1.0%Hold$542.50 3.1%31.8689 of 5 starsTrending News1.33%JPMJPMorgan Chase & Co.$333.79+0.7%Moderate Buy$362.96 8.7%284.3088 of 5 starsTrending NewsEarnings ReportAnalyst ForecastAnalyst Revision1.07%XOMExxonMobil$177.09+1.7%Hold$164.78 -6.9%253.5359 of 5 starsTrending NewsAnalyst Revision0.95%VVisa$391.21-1.2%Buy$425.52 8.8%374.4129 of 5 starsTrending NewsAnalyst Forecast0.93%JNJJohnson & Johnson$253.44+1.9%Moderate Buy$273.61 8.0%254.4602 of 5 starsTrending NewsEarnings ReportDividend AnnouncementAnalyst ForecastAnalyst Revision0.80%WMTWalmart$115.59+2.9%Moderate Buy$131.74 14.0%394.2842 of 5 starsTrending News0.77%INTCIntel$98.45-4.2%Hold$109.06 10.8%504.1024 of 5 starsTrending NewsAnalyst RevisionGap Down0.71%ABBVAbbVie$284.16+3.6%Moderate Buy$277.18 -2.5%304.1599 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision0.69%COSTCostco Wholesale$975.67+2.2%Moderate Buy$1,046.27 7.2%334.2305 of 5 starsTrending NewsAnalyst Revision0.69%MAMastercard$602.82-0.3%Moderate Buy$681.56 13.1%344.7892 of 5 starsTrending NewsInsider Trade0.67%CSCOCisco Systems$113.58-1.3%Moderate Buy$128.52 13.2%264.9121 of 5 starsPositive NewsAnalyst Upgrade0.64%LRCXLam Research$287.01-4.7%Moderate Buy$364.59 27.0%324.9685 of 5 starsTrending NewsUpcoming EarningsAnalyst RevisionGap Down0.64%AMATApplied Materials$448.36-3.4%Moderate Buy$640.20 42.8%394.9138 of 5 starsTrending NewsAnalyst ForecastAnalyst RevisionGap Down0.64%KOCocaCola$91.74+1.8%Moderate Buy$95.95 4.6%234.1323 of 5 starsTrending NewsAnalyst Forecast This page (NYSEARCA:TOV) was last updated on 10/14/2026 by MarketBeat.com Staff. From Our PartnersINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...Paradigm Press | SponsoredElon's next millionaires start October 24?SpaceX minted 4,400 millionaires in a single day, and Tesla has turned more than 5,000 employees into milliona...Behind the Markets | SponsoredTrump's about to unleash his Midterm WeaponTrump is turning the midterms into a referendum on American energy, pushing for more oil, more gas, and lower ...Monument Traders Alliance | SponsoredWhy Some AI Stocks Already Surged Over 300 PercentJason Bodner's system flagged Nvidia before a 7000 percent run, Super Micro Computer before a 2600 percent run...Brownstone Research | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredMicroscopic footage reveals immune cells destroying cancer cellsTime-lapse footage from a recent clinical study shows Natural Killer cells attacking and eliminating cancer ce...Market Tactic | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding JLens 500 Jewish Advocacy U.S. ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share JLens 500 Jewish Advocacy U.S. ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
